$SANG Income Statement | Understand Stock

$SANG

$4.59 -$0.04 (0.86%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Jun 30, 2026	FY2024 12 months to Jun 30, 2025	FY2023 12 months to Jun 30, 2024	FY2022 12 months to Jun 30, 2023	FY2021 12 months to Jun 30, 2022
Revenue
Cost of sales
Inventory write-down
Gross profit
Expenses
Sales and marketing
Research and development
General and administration
Foreign currency exchange (gain) loss
Total expenses

Income (loss) before interest expense (net), business integration costs, exchange listing expense, gain on change in fair value of consideration payable, business acquisition costs, goodwill impairment and income taxes
Amortization of intangible assets
Interest expense (net)
Business acquisition costs
Business integration costs
Exchange listing expense
Restructuring and business integration costs
Loss on change in fair value of consideration payable
Goodwill impairment
Total non-operating expenses
Loss on sale, divestiture of subsidiary
Loss before income tax
Provision for income taxes
Current (Note 11)
Current
Deferred
Net loss
Other comprehensive loss
Items to be reclassified to net loss
Loss in fair value of interest rate swaps, net of tax
Foreign currency translation gain
Comprehensive loss
Loss per share
Basic (in dollars per share)
Diluted (in dollars per share)
Weighted average number of shares outstanding
Basic (in shares)
Diluted (in shares)

Comments